Work

A Head-to-Head Comparison of Aripiprazole and Risperidone for Safety and Treating Autistic Disorders, a Randomized Double Blind Clinical Trial

Year: 2013

Type: article

Study designs: Randomized Controlled Trial, Clinical Trial

Source: Child Psychiatry & Human Development

DOI: 10.1007/s10578-013-0390-x

Authors: Ahmad Ghanizadeh, Aliakbar Sahraeizadeh, Michael Berk

Institutions: Shiraz University, Shiraz University of Medical Sciences, Deakin University, The University of Melbourne, Florey Institute of Neuroscience and Mental Health

Language: English

Topic: Autism Spectrum Disorder Research

Subfield: Cognitive Neuroscience

Field: Neuroscience

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: green

Funders: Bristol-Myers Squibb, Eli Lilly and Company, Pfizer, Sanofi, Geelong Region Medical Research Foundation, Beyond Blue, Shiraz University of Medical Sciences, Shiraz University, Servier, H. Lundbeck A/S, National Institutes of Health, National Health and Medical Research Council, Cilag

OpenAlex ID: W1969516074

FWCI: 4.313

Cites: 26

Cited by: 135

Related to: 10